Global Drug Discovery Informatics Market Research Report 2023

Publication ID:

PB503237719

Publication Date:

March 16, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Highlights
The global Drug Discovery Informatics market was valued at US$ 1 million in 2022 and is anticipated to reach US$ 1 million by 2029, witnessing a CAGR of 9.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Drug Discovery Informatics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Drug Discovery Informatics is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Drug Discovery Informatics in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Drug Discovery Informatics include IBM, Infosys, Thermo Fisher Scientific, Perkinelmer, 厂肠丑谤枚诲颈苍驳别谤, Dassault Syst猫mes, Charles River Laboratories, Selvita and Certara, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Discovery Informatics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Informatics.
The Drug Discovery Informatics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Discovery Informatics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery Informatics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
IBM
Infosys
Thermo Fisher Scientific
Perkinelmer
厂肠丑谤枚诲颈苍驳别谤
Dassault Syst猫mes
Charles River Laboratories
Selvita
Certara
GVK Biosciences
Collaborative Drug Discovery
Openeye Scientific Software
IO Informatics
Novo Informatics
Segment by Type
Software
Services
Segment by Application
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Discovery Informatics companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Discovery Informatics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Software
1.2.3 Services
1.3 Market by Application
1.3.1 Global Drug Discovery Informatics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Contract Research Organizations (CROs)
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery Informatics Market Perspective (2018-2029)
2.2 Drug Discovery Informatics Growth Trends by Region
2.2.1 Global Drug Discovery Informatics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug Discovery Informatics Historic Market Size by Region (2018-2023)
2.2.3 Drug Discovery Informatics Forecasted Market Size by Region (2024-2029)
2.3 Drug Discovery Informatics Market Dynamics
2.3.1 Drug Discovery Informatics Industry Trends
2.3.2 Drug Discovery Informatics Market Drivers
2.3.3 Drug Discovery Informatics Market Challenges
2.3.4 Drug Discovery Informatics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery Informatics Players by Revenue
3.1.1 Global Top Drug Discovery Informatics Players by Revenue (2018-2023)
3.1.2 Global Drug Discovery Informatics Revenue Market Share by Players (2018-2023)
3.2 Global Drug Discovery Informatics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Discovery Informatics Revenue
3.4 Global Drug Discovery Informatics Market Concentration Ratio
3.4.1 Global Drug Discovery Informatics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Informatics Revenue in 2022
3.5 Drug Discovery Informatics Key Players Head office and Area Served
3.6 Key Players Drug Discovery Informatics Product Solution and Service
3.7 Date of Enter into Drug Discovery Informatics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery Informatics Breakdown Data by Type
4.1 Global Drug Discovery Informatics Historic Market Size by Type (2018-2023)
4.2 Global Drug Discovery Informatics Forecasted Market Size by Type (2024-2029)
5 Drug Discovery Informatics Breakdown Data by Application
5.1 Global Drug Discovery Informatics Historic Market Size by Application (2018-2023)
5.2 Global Drug Discovery Informatics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drug Discovery Informatics Market Size (2018-2029)
6.2 North America Drug Discovery Informatics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Drug Discovery Informatics Market Size by Country (2018-2023)
6.4 North America Drug Discovery Informatics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Discovery Informatics Market Size (2018-2029)
7.2 Europe Drug Discovery Informatics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Drug Discovery Informatics Market Size by Country (2018-2023)
7.4 Europe Drug Discovery Informatics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery Informatics Market Size (2018-2029)
8.2 Asia-Pacific Drug Discovery Informatics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Drug Discovery Informatics Market Size by Region (2018-2023)
8.4 Asia-Pacific Drug Discovery Informatics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Discovery Informatics Market Size (2018-2029)
9.2 Latin America Drug Discovery Informatics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Drug Discovery Informatics Market Size by Country (2018-2023)
9.4 Latin America Drug Discovery Informatics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery Informatics Market Size (2018-2029)
10.2 Middle East & Africa Drug Discovery Informatics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Drug Discovery Informatics Market Size by Country (2018-2023)
10.4 Middle East & Africa Drug Discovery Informatics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Detail
11.1.2 IBM Business Overview
11.1.3 IBM Drug Discovery Informatics Introduction
11.1.4 IBM Revenue in Drug Discovery Informatics Business (2018-2023)
11.1.5 IBM Recent Development
11.2 Infosys
11.2.1 Infosys Company Detail
11.2.2 Infosys Business Overview
11.2.3 Infosys Drug Discovery Informatics Introduction
11.2.4 Infosys Revenue in Drug Discovery Informatics Business (2018-2023)
11.2.5 Infosys Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Drug Discovery Informatics Introduction
11.3.4 Thermo Fisher Scientific Revenue in Drug Discovery Informatics Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Perkinelmer
11.4.1 Perkinelmer Company Detail
11.4.2 Perkinelmer Business Overview
11.4.3 Perkinelmer Drug Discovery Informatics Introduction
11.4.4 Perkinelmer Revenue in Drug Discovery Informatics Business (2018-2023)
11.4.5 Perkinelmer Recent Development
11.5 厂肠丑谤枚诲颈苍驳别谤
11.5.1 厂肠丑谤枚诲颈苍驳别谤 Company Detail
11.5.2 厂肠丑谤枚诲颈苍驳别谤 Business Overview
11.5.3 厂肠丑谤枚诲颈苍驳别谤 Drug Discovery Informatics Introduction
11.5.4 厂肠丑谤枚诲颈苍驳别谤 Revenue in Drug Discovery Informatics Business (2018-2023)
11.5.5 厂肠丑谤枚诲颈苍驳别谤 Recent Development
11.6 Dassault Syst猫mes
11.6.1 Dassault Syst猫mes Company Detail
11.6.2 Dassault Syst猫mes Business Overview
11.6.3 Dassault Syst猫mes Drug Discovery Informatics Introduction
11.6.4 Dassault Syst猫mes Revenue in Drug Discovery Informatics Business (2018-2023)
11.6.5 Dassault Syst猫mes Recent Development
11.7 Charles River Laboratories
11.7.1 Charles River Laboratories Company Detail
11.7.2 Charles River Laboratories Business Overview
11.7.3 Charles River Laboratories Drug Discovery Informatics Introduction
11.7.4 Charles River Laboratories Revenue in Drug Discovery Informatics Business (2018-2023)
11.7.5 Charles River Laboratories Recent Development
11.8 Selvita
11.8.1 Selvita Company Detail
11.8.2 Selvita Business Overview
11.8.3 Selvita Drug Discovery Informatics Introduction
11.8.4 Selvita Revenue in Drug Discovery Informatics Business (2018-2023)
11.8.5 Selvita Recent Development
11.9 Certara
11.9.1 Certara Company Detail
11.9.2 Certara Business Overview
11.9.3 Certara Drug Discovery Informatics Introduction
11.9.4 Certara Revenue in Drug Discovery Informatics Business (2018-2023)
11.9.5 Certara Recent Development
11.10 GVK Biosciences
11.10.1 GVK Biosciences Company Detail
11.10.2 GVK Biosciences Business Overview
11.10.3 GVK Biosciences Drug Discovery Informatics Introduction
11.10.4 GVK Biosciences Revenue in Drug Discovery Informatics Business (2018-2023)
11.10.5 GVK Biosciences Recent Development
11.11 Collaborative Drug Discovery
11.11.1 Collaborative Drug Discovery Company Detail
11.11.2 Collaborative Drug Discovery Business Overview
11.11.3 Collaborative Drug Discovery Drug Discovery Informatics Introduction
11.11.4 Collaborative Drug Discovery Revenue in Drug Discovery Informatics Business (2018-2023)
11.11.5 Collaborative Drug Discovery Recent Development
11.12 Openeye Scientific Software
11.12.1 Openeye Scientific Software Company Detail
11.12.2 Openeye Scientific Software Business Overview
11.12.3 Openeye Scientific Software Drug Discovery Informatics Introduction
11.12.4 Openeye Scientific Software Revenue in Drug Discovery Informatics Business (2018-2023)
11.12.5 Openeye Scientific Software Recent Development
11.13 IO Informatics
11.13.1 IO Informatics Company Detail
11.13.2 IO Informatics Business Overview
11.13.3 IO Informatics Drug Discovery Informatics Introduction
11.13.4 IO Informatics Revenue in Drug Discovery Informatics Business (2018-2023)
11.13.5 IO Informatics Recent Development
11.14 Novo Informatics
11.14.1 Novo Informatics Company Detail
11.14.2 Novo Informatics Business Overview
11.14.3 Novo Informatics Drug Discovery Informatics Introduction
11.14.4 Novo Informatics Revenue in Drug Discovery Informatics Business (2018-2023)
11.14.5 Novo Informatics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

IBM
Infosys
Thermo Fisher Scientific
Perkinelmer
厂肠丑谤枚诲颈苍驳别谤
Dassault Syst猫mes
Charles River Laboratories
Selvita
Certara
GVK Biosciences
Collaborative Drug Discovery
Openeye Scientific Software
IO Informatics
Novo Informatics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂